09:11 AM EDT, 05/01/2025 (MT Newswires) -- Moderna ( MRNA ) reported a Q1 loss Thursday of $2.52 per diluted share, narrower than a loss of $3.07 a year earlier.

Analysts polled by FactSet expected a loss of $3.17.

Revenue for the quarter ended March 31 was $108 million compared with $167 million a year earlier.

Analysts surveyed by FactSet expected $106.2 million.

The company reiterated its 2025 revenue guidance of $1.50 billion to $2.50 billion. Analysts polled by FactSet expect $2.09 billion.

Shares of the company fell by nearly 5% in premarket activity.